MZMichał Zieliński

Michał Zieliński

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michał Zieliński has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Barbara Dolińska

    Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Kasztanowa 3, 41-200 Sosnowiec, Poland

    2 shared publications
  • Florian Ryszka

    Pharmaceutical Research and Production Plant "Biochefa", Sosnowiec, Poland

    2 shared publications
  • Zbigniew Dobrzański

    Department of Animal Hygiene and Animal Welfare, Wrocław University of Environmental and Life Sciences, Wrocław, Poland

    2 shared publications
  • Adam Pudełko

    Gyncentrum, Laboratory of Molecular Biology and Virology, 40-851 Katowice, Poland

    1 shared publication
  • Anna Fila-Daniłow

    Department of Medical Genetics, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Katowice, Poland

    1 shared publication
  • Barbara Łasut-Szyszka

    Center for Translational Research and Molecular Biology of Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-101 Gliwice, Poland

    1 shared publication

Latest Publications

  • Acute Stress Affects the Relaxin/Insulin‐Like Family Peptide Receptor 3 mRNA Expression in Brain of Pubertal Male Wistar Rats

    by Miłosz Gołyszny, Michał Zieliński, Ewa Obuchowicz

    The current literature suggests that relaxin‐3/relaxin/insulin‐like family peptide receptor 3 (RLN‐3/RXFP‐3) system is involved in the pathophysiology of affective disorders because the results of anatomical and pharmacological studies have shown that the RLN‐3 signaling pathway plays a role in modulating the stress response, anxiety, arousal, depression‐like behavior, and neuroendocrine homeostasis. The risk of developing mental illnesses in adulthood is increased by exposure to stress in early periods of life. The available data indicate that puberty is especially characterized by the development of the neural system and emotionality and is a “stress‐sensitive” period. The presented study assessed the short‐term changes in the expression of RLN‐3 and RXFP‐3 mRNA in the stress‐dependent brain regions in male pubertal Wistar rats that had been subjected to acute stress. Three stressors were applied from 42 to 44 postnatal days (first day: a single forced swim; second day: stress on an elevated platform that was repeated three times; third day: restraint stress three times). Anxiety (open field, elevated plus maze test) and anhedonic‐like behavior (sucrose preference test) were estimated during these tests. The corticosterone (CORT) levels and blood morphology were estimated. We found that the RXFP‐3 mRNA expression decreased in the brainstem, whereas it increased in the hypothalamus 72 h after acute stress. These molecular changes were accompanied by the increased levels of CORT and anxiety‐like behavior detected in the open field test that had been conducted earlier, that is, 24 h after the stress procedure. These findings shed new light on the neurochemical changes that are involved in the compensatory response to adverse events in pubertal male rats and support other data that suggest a regulatory interplay between the RLN‐3 pathway and the hypothalamus–pituitary–adrenal axis activity in the mechanisms of anxiety‐like behavior.


  • Methylglyoxal (MGO) inhibits proliferation and induces cell death of human glioblastoma multiforme T98G and U87MG cells

    by Monika Paul-Samojedny, Barbara Łasut, Adam Pudełko, Anna Fila-Daniłow, Małgorzata Kowalczyk, Renata Suchanek-Raif, Michał Zieliński, Paulina Borkowska, Jan Kowalski


  • Permeation of iodide from iodine-enriched yeast through porcine intestine.

    by Florian Ryszka, Barbara Dolińska, Michał Zieliński, Dagmara Chyra, Zbigniew Dobrzański

    Iodine deficiency is a common phenomenon, threatening the whole global human population. Recommended daily intake of iodine is 150 μg for adults and 250 μg for pregnant and breastfeeding women. About 50% of human population can be at risk of moderate iodine deficiency. Due to this fact, increased iodine supplementation is recommended, through intake of iodized mineral water and salt iodization. The aim of this study was to investigate permeation and absorption of iodide from iodine bioplex (experimental group) in comparison with potassium iodide (controls). Permeation and absorption processes were investigated in vitro using a porcine intestine. The experimental model was based on a standard Franz diffusion cell (FD-Cell). The iodine bioplex was produced using Saccharomyces cerevisiae yeast and whey powder: iodine content - 388 μg/g, total protein - 28.5%, total fat - 0.9%., glutamic acid - 41.2%, asparaginic acid - 29.4%, lysine - 24.8%; purchased from: F.Z.N.P. Biochefa, Sosnowiec, Poland. Potassium iodide was used as controls, at 388 μg iodine concentration, which was the same as in iodine-enriched yeast bioplex. A statistically significant increase in iodide permeation was observed for iodine-enriched yeast bioplex in comparison with controls - potassium iodide. After 5h the total amount of permeated iodide from iodine-enriched yeast bioplex was 85%, which is ~ 2-fold higher than controls - 37%. Iodide absorption was by contrast statistically significantly higher in controls - 7.3%, in comparison with 4.5% in experimental group with iodine-enriched yeast bioplex. Presented results show that iodide permeation process dominates over absorption in case of iodine-enriched yeast bioplex.

  • Open Access

    Influence of Incubation Conditions on Hydrolysis Efficiency and Iodine Enrichment in Baker’s Yeast

    by Barbara Dolińska, Michał Zieliński, Zbigniew Dobrzański, Katarzyna Chojnacka, Sebastian Opaliński, Florian Ryszka

    The influence of incubation conditions, enzyme type, hydrolysis time, and potassium iodide concentration on hydrolysis and iodine enrichment were studied in supernatant and pellets of Saccharomyces cervisiae hydrolysates. The type of enzyme used and incubation time significantly influence hydrolysis efficiency and protein concentration in supernatant and pellet. The highest protein hydrolysis efficiency was obtained by 24-h incubation with papain. Significantly lower values were observed for pepsin and autolysis. The potassium iodide concentration influences the iodine content of supernatant and pellet, but not hydrolysis. Iodide enrichment of supernatant and pellet depends on the concentration of iodide using during incubation. High concentration of iodide and long incubation times were the conditions for optimal iodide enrichment and high-protein hydrolysates. The optimal hydrolysis efficiency and iodine enrichment were obtained during 24-h incubation with papain in a 4.5-mM potassium iodide medium. The efficiency reached 98.22% with iodine concentrations of 2,664.91 and 9,200.67 μg/g iodine in pellet and supernatant, respectively.